Human synovial mast cells: I. Ultrastructural in situ and in vitro immunologic characterization

Arthritis and Rheumatism

Volumn 39, Issue 7, 1996, Pages 1222-1233

  De Paulis, Amato ^a   Marinò, Isabella ^a   Ciccarelli, Anna ^a   De Crescenzo, Gennaro ^a   Concardi, Monica ^b   Verga, Laura ^b   Arbustini, Eloisa ^b   Marone, Gianni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMASE; COMPLEMENT COMPONENT C5A; HISTAMINE; LEUKOTRIENE C4; PROSTAGLANDIN D2; STEM CELL FACTOR; SUBSTANCE P; TRYPTASE;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME LOCALIZATION; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; MAJOR CLINICAL STUDY; MAST CELL; MAST CELL DEGRANULATION; OSTEOARTHRITIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RHEUMATOID ARTHRITIS; SYNOVIUM;

ADULT; AGED; ANTIBODIES, ANTI-IDIOTYPIC; CELL MOVEMENT; CHYMASES; HISTAMINE; HUMANS; LEUKOTRIENE C4; MAST CELLS; MIDDLE AGED; P-METHOXY-N-METHYLPHENETHYLAMINE; PROSTAGLANDIN D2; SERINE ENDOPEPTIDASES; STEM CELL FACTOR; SUBSTANCE P; SYNOVIAL MEMBRANE; TRYPTASES;

EID: 0029956124     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390723     Document Type: Article

References (62)

1. Janes J, McDonald JR: Mast cells: their distribution in various human tissues. Arch Pathol Lab Med 45:622-634, 1948
2. Lever JD, Ford EHR: Histological, histochemical and electron microscopic observations on synovial membrane. Anat Rec 132: 525-543, 1958
3. Castor CW: The microscopic structure of normal human synovial tissue. Arthritis Rheum 3:140-151, 1960
4. Wynne-Roberts CR, Anderson CH, Turano AM, Baron M: Light-and electron-microscopic findings of juvenile rheumatoid arthritis synovium: comparison with normal human synovium. Semin Arthritis Rheum 7:287-302, 1978
5. Godfrey HP, Ilardi C, Engber W, Graziano FM: Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum 27:852-856, 1984
6. Malone DG, Irani A-M, Schwartz LB, Barrett KE, Metcalfe DD: Mast cell numbers and histamine levels in synovial fluids from patients with diverse arthritides. Arthritis Rheum 29:956-963, 1986
7. Kopicky-Burd JA, Kagey-Sobotka A, Peters SP, Dvorak AM, Lennox DW, Lichtenstein LM, Wigley FM: Characterization of human synovial mast cells. J Rheumatol 15:1326-1333, 1988
8. Arnason JA, Malone DG: Role of mast cells in arthritis. In, Human Basophils and Mast Cells: Clinical Aspect. Edited by G Marone. Basel, Karger, 1995
9. Ferwin DB, Cleland LG, Jonsson JR, Robertson PW: Histamine levels in human synovial fluid. J Rheumatol 13:13-14, 1986
10. Gruber B: Activation of rheumatoid synovial mast cells: role of IgE-associated antiglobulins. Monogr Allergy 26:120-134, 1989
11. Mican JM, Metcalfe DD: Arthritis and mast cell activation. J Allergy Clin Immunol 86:677-683, 1990
12. Gruber B, Poznansky M, Boss E, Partin J, Gorevic P, Kaplan AP: Characterization and functional studies of rheumatoid synovial mast cell: activation by segretagogues, anti-IgE, and histamine-releasing lymphokine. Arthritis Rheum 29:944-955, 1986
13. Bridges AJ, Malone DG, Jicinsky J, Chen M, Ory P, Engber W, Graziano FM: Human synovial mast cell involvement in rheumatoid arthritis and OA: relationship to disease type, clinical activity, and antirheumatic therapy. Arthritis Rheum 34:1116-1124, 1991
14. Verbsky JW, McAllister PK, Malone DJ: Demonstration of mast cell activation and histamine release in human synovial explants following exposure to calcium ionophore A23187, compound 48/80, and rabbit IgG anti-human IgE, but not morphine sulfate. Inflamm Res (in press)
15. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB: Two types of human mast cell that have distinct neutral protease compositions. Proc Natl Acad Sci U S A 83:4464-4468, 1986
16. + cells. J Immunol 146:2374-2381, 1991
17. De Paulis A, Cirillo R, Ciccarelli A, de Crescenzo G, Oriente A, Marone G: Characterization of the anti-inflammatory effect of FK-506 on human mast cells. J Immunol 147:4278-4285, 1991
18. Patella V, Marinò I, Lampärter B, Arbustini E, Adt M, Marone G: Human heart mast cells: isolation, purification, and immunologic characterization. J Immunol 154:2855-2865, 1995
19. De Paulis A, Stellato C, Cirillo R, Ciccarelli A, Oriente A, Marone G: Anti-inflammatory effect of FK-506 on human skin mast cells. J Invest Dermatol 99:723-728, 1992
20. De Paulis A, Valentini G, Spadaro G, Lupoli S, Tirri G, Marone G: Human basophil releasability. VIII. Increased basophil releasability in patients with sclevoderma. Arthritis Rheum 34:1289-1296, 1991
21. Casolaro V, Galeone D, Giacummo A, Sanduzzi A, Melillo G, Marone G: Human basophil/mast cell releasability. V. Functional comparisons of cells obtained from peripheral blood, lung parenchyma and from bronchoalveolar lavage in asthmatics. Am Rev Respir Dis 139:1375-1382, 1989
22. Siraganian RP: An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal Biochem 57:383-394, 1974
23. Patella V, Casolaro V, Ciccarelli A, Pettit GR, Columbo M, Marone G: The antineoplastic bryostatins affect human basophils and mast cells differently. Blood 85:1272-1281, 1995
24. Stellato C, Cirillo R, de Paulis A, Casolaro V, Patella V, Mastronardi P, Mazzarella B, Marone G: Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release. Anesthesiology 77:932-940, 1992
25. Lawrence ID, Warner JA, Cohan VL, Hubbard WC, Kagey-Sobotka A, Lichtenstein LM: Purification and characterization of human skin mast cells: evidence for human mast cell heterogeneity. J Immunol 139:3062-3069, 1987
26. Stellato C, de Paulis A, Cirillo R, Mastronardi P, Mazzarella B, Marone G: Heterogeneity of human mast cells and basophils in response to muscle relaxants. Anesthesiology 74:1078-1086, 1991
27. Cirillo R, Triggiani M, Siri L, Ciccarelli A, Pettit GR, Condorelli M, Marone G: Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. J Immunol 144:3891-3897, 1990
28. Arbustini E, Pucci A, Grasso M, Diegoli M, Pozzi R, Gavazzi A, Graziano G, Campana C, Goggi C, Martinelli L, Silini E, Specchia G, Vigano M, Solcia E: Expression of natriurelic peptide in ventricular myocardium of failing human hearts and its correlation with the severity of clinical and hemodynamic impairment. Am J Cardiol 66:973-980, 1990
29. Snedecor GW, Cochran WG: Statistical Methods. Ames, IA, Iowa State University Press, 1980
30. Dvorak AM, Massey W, Warner J, Kissel LS, Kagey-Sobotka A, Lichtenstein LM: IgE-mediated anaphylactic degranulation of isolated human skin mast cells. Blood 77:569-578, 1991
31. Massey WA, Guo G-B, Dvorak AM, Hubbard WC, Bhagavan BS, Cohan VL, Warner JA, Kagey-Sobotka A, Lichtenstein LM: Human uterine mast cells: isolation, purification, characterization, ultrastructure, and pharmacology. J Immunol 147:1621-1627, 1991
32. Hunder GG, Gleich GJ: Immunoglobulin E (IgE) levels in serum and synovial fluid in rheumatoid arthritis. Arthritis Rheum 17:955-963, 1974
33. Zuraw BL, O'Hair CH, Vaughan JH, Mathison DA, Curd JG, Katz DH: Immunoglobulin E-rhcumatoid factor in the serum of patients with rheumatoid arthritis, asthma, and other diseases. J Clin Invest 68:1610-1613, 1981
34. Merétey K, Falus A, Böhm U, Permin H, Wiik A: IgE class immune complexes in Felty's syndrome: characterization of antibody activities in isolated complexes. Ann Rheum Dis 43:246-250, 1984
35. Gruber B, Ballan D, Gorevic PD: IgE rheumatoid factors: quantification in synovial fluid and ability to induce synovial mast cell histamine release. Clin Exp Immunol 71:289-294, 1988
36. Burastero SE, Lo Pinto G, Goletti D, Cutolo M, Burlando L, Falagiani P: Rheumatoid arthritis with monoclonal IgE rheumatoid factor. J Rheumatol 20:489-494, 1993
37. εRI): analysis of functional domains of the α-subunit with monoclonal antibodies. J Biol Chem 266:11245-11251, 1991
38. Ward PA, Zvaifler NJ: Complement-derived leukotactic factors in inflammatory synovial fluids of humans. J Clin Invest 50:606-616, 1971
39. Moxley G, Ruddy S: Elevated C3 anaphylatoxin levels in synovial fluids from patients with rheumatoid arthritis. Arthritis Rheum 28:1089-1094, 1985
40. Grönblad M, Konttinen YT, Korkala O, Liesi P, Hukkanen M, Polak JM: Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 15:1807-1810, 1988
41. Pereira da Silva JA, Carmo-Fonseca M: Peptide containing nerves in human synovium: immunohistochemical evidence for decreased innervation in rheumatoid arthritis. J Rheumatol 17:1592-1599, 1990
42. Devillier P, Weill B, Renoux M, Menkès C, Pradelles P: Elevated levels of tachykinin-like immunoreactivity in joint fluids from patients with rheumatic inflammatory diseases (letter). N Engl J Med 314:1323, 1986
43. Tainsh KR, Pearce FL: Mast cell heterogeneity: evidence that mast cells isolated from various connective tissue locations in the rat display markedly grades phenotypes. Int Arch Allergy Immunol 98:26-34, 1992
44. Benyon RC, Lowman MA, Church MK: Human skin mast cells: their dispersion, purification, and secretory characterization. J Immunol 138:861-867, 1987
45. Marone G, Patella V, de Crescenzo G, Genovese A, Adt M: Human heart mast cells in anaphylaxis and cardiovascular disease. Int Arch Allergy Immunol 107:72-75, 1995
46. Church MK, Pao J-KG, Holgate ST: Characterization of histamine secretion from mechanically dispersed human lung mast cells: effects of anti-IgE, calcium ionophore A23187, compound 48/80, and basic polypeptides. J Immunol 129:2116-2121, 1982
47. Tsai M, Shih L-S, Newlands GFJ, Takeishi T, Langley KE, Zsebo KM, Miller HRP, Geissler EN, Galli SJ: The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo: analysis by anatomical distribution, histochemistry, and protease phenotype. J Exp Med 174:125-131, 1991
48. Columbo M, Horowitz EM, Botana LM, MacGlashan DW Jr, Bochner BS, Gillis S, Zsebo KM, Galli S, Lichtenstein LM: The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J Immunol 149:599-608, 1992
49. De Paulis A, Ciccarelli A, Cirillo R, de Crescenzo G, Columbo M, Marone G: Modulation of human lung mast cell function by the c-kit receptor ligand. Int Arch Allergy Immunol 99:326-329, 1992
50. Craig SS, Scheehter NM, Schwarte LB: Ultrastructural analysis of human T and TC mast cells identified by immunoelectron microscopy. Lab Invest 58:682-691, 1988
51. Marone G, Casolaro V, Paganelli R, Quinti I: IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells. J Invest Dermatol 93:246-252, 1989
52. Hide M, Francis DM, Grattan CEH, Hakimi J, Kochan JP, Greaves MW: Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 328:1599-1604, 1993
53. Marone G, Poto S, Celestino D, Bonini S: Human basophil releasability. III. Genetic control of human basophil releasability. J Immunol 137:3588-3592, 1986
54. Hukkanen M, Grönblad M, Rees R, Konttinen YT, Gibson SJ, Hietanen J, Polak JM, Brewerton DA: Regional distribution of mast cells and peptide containing nerves in normal and adjuvant arthritic rat synovium. J Rheumatol 18:177-183, 1991
55. Lotz M, Carson DA, Vaughan JH: Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science 235:893-895, 1987
56. Levine JD, Moskowitz MA, Basbaum AI: The contribution of neurogenic inflammation in experimental arthritis. J Immunol 135:843-847, 1985
57. Schulman ES, MacGlashan DW Jr, Peters SP, Schleimer RP, Newball HH, Lichtenstein LM: Human lung mast cells: purification and characterization. J Immunol 129:2662-2267, 1982
58. De Clerck LS, Struyf NJ, Bridts CH, Breedveld FC, Westedt ML, Cats A, Stevens WJ: IgE-containing immune complexes in synovial fluid of patients with rheumatoid arthritis. Clin Rheumatol 9:176-181, 1990
59. Russell JD, Russell SB, Trupin KM: The effect of histamine on the growth of cultured fibroblasts isolated from normal and keloid tissue. J Cell Physiol 93:389-394, 1977
60. Ruoss SJ, Hartmann T, Caughey GH: Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 88:493-499, 1991
61. Baud L, Perez J, Denis M, Ardaillou R: Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin. J Immunol 138:1190-1195, 1987
62. Mizutani H, Schechter N, Lazarus G, Black RA, Kupper TS: Rapid and specific conversion of precursor interleukin 1β (IL-1β) to an active IL-1 species by human mast cell chymase. J Exp Med 174:821-825, 1991